GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » YoY EPS Growth

Acticor Biotech (XPAR:ALACT) YoY EPS Growth : -26.09% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Acticor Biotech's YoY EPS Growth for the quarter that ended in Jun. 2023 was -26.09%.

Acticor Biotech's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was €-0.87.

Acticor Biotech YoY EPS Growth Historical Data

The historical data trend for Acticor Biotech's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech YoY EPS Growth Chart

Acticor Biotech Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EPS Growth
Get a 7-Day Free Trial - 15.67 -51.57 -123.14 8.02

Acticor Biotech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only -72.31 -59.35 -23.21 -25.20 -26.09

Acticor Biotech YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Acticor Biotech's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EPS Growth (A: Dec. 2022 )
=(Earnings per Share (Diluted) (A: Dec. 2022 )-Earnings per Share (Diluted) (A: Dec. 2021 ))/ | Earnings per Share (Diluted) (A: Dec. 2021 ) |
=(-1.49--1.62)/ | -1.62 |
=8.02 %

Acticor Biotech's YoY EPS Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EPS Growth (Q: Jun. 2023 )
=(Earnings per Share (Diluted) (Q: Jun. 2023 )-Earnings per Share (Diluted) (Q: Jun. 2022 )) / | Earnings per Share (Diluted) (Q: Jun. 2022 )) |
=(-0.87--0.69)/ | -0.69 |
=-26.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acticor Biotech YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » YoY EPS Growth
Comparable Companies
XPAR:ALCLS XPAR:ABNX XPAR:ALGEN XPAR:GNRO XPAR:ALVIO XPAR:PHXM XPAR:ALDVI XPAR:SIGHT XPAR:ALCOX XPAR:ALVAL OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
7V7:Germany
Address
82 Avenue du Maine, Wojo Building, Paris, FRA, 75014
Website
https://www.acticor-biotech.com
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines